Search

Search Constraints

You searched for: Author/Creator Perentesis, John P.

Search Results

1. A phase 1 study of the c‐Met inhibitor, tivantinib (ARQ197) in children with relapsed or refractory solid tumors: A Children's Oncology Group study phase 1 and pilot consortium trial (ADVL1111). Issue 11 (27th April 2017)

2. A Phase 2 study of bortezomib combined with either idarubicin/cytarabine or cytarabine/etoposide in children with relapsed, refractory or secondary acute myeloid leukemia: A report from the Children's Oncology Group. Issue 10 (29th June 2014)

3. A phase I trial of MK‐2206 in children with refractory malignancies: A Children's Oncology Group study. Issue 7 (24th March 2014)

4. AAML0523: A report from the Children's Oncology Group on the efficacy of clofarabine in combination with cytarabine in pediatric patients with recurrent acute myeloid leukemia. Issue 16 (25th April 2014)

5. AAML0523: A report from the Children's Oncology Group on the efficacy of clofarabine in combination with cytarabine in pediatric patients with recurrent acute myeloid leukemia. Issue 16 (25th April 2014)

9. Differential transcriptome response to proton versus X-ray radiation reveals novel candidate targets for combinatorial PT therapy in lymphoma. (February 2021)

10. Low dose decitabine in very high risk relapsed or refractory acute myeloid leukaemia in children and young adults. (23rd February 2013)